560 related articles for article (PubMed ID: 27256713)
1. The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions.
Abdollahi-Roodsaz S; Abramson SB; Scher JU
Nat Rev Rheumatol; 2016 Aug; 12(8):446-55. PubMed ID: 27256713
[TBL] [Abstract][Full Text] [Related]
2. The role of the gut microbiome in systemic inflammatory disease.
Clemente JC; Manasson J; Scher JU
BMJ; 2018 Jan; 360():j5145. PubMed ID: 29311119
[TBL] [Abstract][Full Text] [Related]
3. The human gut microbiota and its interactive connections to diet.
Milani C; Ferrario C; Turroni F; Duranti S; Mangifesta M; van Sinderen D; Ventura M
J Hum Nutr Diet; 2016 Oct; 29(5):539-46. PubMed ID: 27161433
[TBL] [Abstract][Full Text] [Related]
4. The role of the microbiome for human health: from basic science to clinical applications.
Mohajeri MH; Brummer RJM; Rastall RA; Weersma RK; Harmsen HJM; Faas M; Eggersdorfer M
Eur J Nutr; 2018 May; 57(Suppl 1):1-14. PubMed ID: 29748817
[TBL] [Abstract][Full Text] [Related]
5. The gut microbiota as a novel regulator of cardiovascular function and disease.
Battson ML; Lee DM; Weir TL; Gentile CL
J Nutr Biochem; 2018 Jun; 56():1-15. PubMed ID: 29427903
[TBL] [Abstract][Full Text] [Related]
6. Gastro-intestinal tract: The leading role of mucosal immunity.
Steinert A; Radulovic K; Niess J
Swiss Med Wkly; 2016; 146():w14293. PubMed ID: 27045424
[TBL] [Abstract][Full Text] [Related]
7. Microbiomes in physiology: insights into 21st-century global medical challenges.
Shehata E; Parker A; Suzuki T; Swann JR; Suez J; Kroon PA; Day-Walsh P
Exp Physiol; 2022 Apr; 107(4):257-264. PubMed ID: 35081663
[TBL] [Abstract][Full Text] [Related]
8. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
Zhu T; Goodarzi MO
Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota and obesity: Impact of antibiotics and prebiotics and potential for musculoskeletal health.
Klancic T; Reimer RA
J Sport Health Sci; 2020 Mar; 9(2):110-118. PubMed ID: 32099719
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota and Cardiovascular Disease.
Witkowski M; Weeks TL; Hazen SL
Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
[TBL] [Abstract][Full Text] [Related]
11. Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications.
Cuevas-Sierra A; Ramos-Lopez O; Riezu-Boj JI; Milagro FI; Martinez JA
Adv Nutr; 2019 Jan; 10(suppl_1):S17-S30. PubMed ID: 30721960
[TBL] [Abstract][Full Text] [Related]
12. The microbiome and its pharmacological targets: therapeutic avenues in cardiometabolic diseases.
Neves AL; Chilloux J; Sarafian MH; Rahim MB; Boulangé CL; Dumas ME
Curr Opin Pharmacol; 2015 Dec; 25():36-44. PubMed ID: 26531326
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease.
Lavelle A; Sokol H
Nat Rev Gastroenterol Hepatol; 2020 Apr; 17(4):223-237. PubMed ID: 32076145
[TBL] [Abstract][Full Text] [Related]
14. How the microbiota shapes rheumatic diseases.
Van de Wiele T; Van Praet JT; Marzorati M; Drennan MB; Elewaut D
Nat Rev Rheumatol; 2016 Jul; 12(7):398-411. PubMed ID: 27305853
[TBL] [Abstract][Full Text] [Related]
15. Postbiotics-A Step Beyond Pre- and Probiotics.
Żółkiewicz J; Marzec A; Ruszczyński M; Feleszko W
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32717965
[TBL] [Abstract][Full Text] [Related]
16. The Gut Microbiota Affects Host Pathophysiology as an Endocrine Organ: A Focus on Cardiovascular Disease.
Busnelli M; Manzini S; Chiesa G
Nutrients; 2019 Dec; 12(1):. PubMed ID: 31892152
[TBL] [Abstract][Full Text] [Related]
17. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota.
Han R; Ma J; Li H
Front Med; 2018 Dec; 12(6):645-657. PubMed ID: 30178233
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
[TBL] [Abstract][Full Text] [Related]
20. Microbe-metabolite-host axis, two-way action in the pathogenesis and treatment of human autoimmunity.
Meng X; Zhou HY; Shen HH; Lufumpa E; Li XM; Guo B; Li BZ
Autoimmun Rev; 2019 May; 18(5):455-475. PubMed ID: 30844549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
